- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.6: 4 residues within 4Å:- Chain A: N.798, S.800, Q.801, F.814
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.9: 8 residues within 4Å:- Chain A: R.454, K.455, S.456, K.459
- Chain B: T.106, N.231, T.233, K.526
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:K.455, B:K.526, B:K.526
NAG-NAG-BMA-MAN-MAN.11: 4 residues within 4Å:- Chain B: N.714, L.919, Q.923, Q.1068
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.919
NAG-NAG-BMA-MAN-MAN.15: 5 residues within 4Å:- Chain C: T.713, N.714, L.919, Q.923, Q.1068
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.7: 4 residues within 4Å:- Chain A: S.701, A.703, E.1069, N.1071
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:A.703
NAG-NAG-BMA.10: 4 residues within 4Å:- Chain A: K.555
- Chain B: N.277, E.278, N.279
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 2 residues within 4Å:- Chain B: A.703, N.1071
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:A.703
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.17: 3 residues within 4Å:- Chain A: N.340, N.367, L.368
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.120
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: N.328, Q.577
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: N.613
- Chain B: K.832
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: N.706
- Chain B: I.791, Y.793
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain A: N.1131
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: S.110, E.130, N.160
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain A: N.654
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain B: N.613, Q.641
- Chain C: K.832
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: Y.652, N.654
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: N.328, P.576, Q.577
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.706
- Chain C: Y.793
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: I.1129, N.1131
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain C: N.328, Q.577
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain C: E.278, N.279
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain A: Q.833
- Chain C: N.613, T.615, Q.641
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: I.791, Y.793
- Chain C: N.706
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain C: N.1131
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain C: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain C: E.130, F.131, N.160, T.162
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: Y.652, N.654
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gobeil, S.M. et al., Structural diversity of the SARS-CoV-2 Omicron spike. Mol.Cell (2022)
- Release Date
- 2022-02-16
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gobeil, S.M. et al., Structural diversity of the SARS-CoV-2 Omicron spike. Mol.Cell (2022)
- Release Date
- 2022-02-16
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C